APA (7th ed.) Citation

A, G., P, S., P, H., K, T., A, M., R, F., . . . W, H. (2003). Open-label, randomized study of pegfilgrastim vs. daily filgrastim as an adjunct to chemotherapy in elderly patients with non-Hodgkin's lymphoma. Leukemia & lymphoma, 44(9), 1503. https://doi.org/10.1080/1042819031000103953

Chicago Style (17th ed.) Citation

A, Grigg, Solal-Celigny P, Hoskin P, Taylor K, McMillan A, Forstpointner R, Bacon P, Renwick J, and Hiddemann W. "Open-label, Randomized Study of Pegfilgrastim Vs. Daily Filgrastim as an Adjunct to Chemotherapy in Elderly Patients with Non-Hodgkin's Lymphoma." Leukemia & Lymphoma 44, no. 9 (2003): 1503. https://doi.org/10.1080/1042819031000103953.

MLA (9th ed.) Citation

A, Grigg, et al. "Open-label, Randomized Study of Pegfilgrastim Vs. Daily Filgrastim as an Adjunct to Chemotherapy in Elderly Patients with Non-Hodgkin's Lymphoma." Leukemia & Lymphoma, vol. 44, no. 9, 2003, p. 1503, https://doi.org/10.1080/1042819031000103953.